| Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer MF Souza, H Kuasne, MC Barros-Filho, HL Cilião, FA Marchi, PE Fuganti, ... PloS one 12 (9), e0184094, 2017 | 127 | 2017 |
| High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma MC Barros-Filho, FA Marchi, CA Pinto, SR Rogatto, LP Kowalski The Journal of Clinical Endocrinology & Metabolism 100 (6), E890-E899, 2015 | 105 | 2015 |
| Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers H Kuasne, IMS Cólus, AF Busso, H Hernandez-Vargas, MC Barros-Filho, ... Clinical epigenetics 7, 1-10, 2015 | 92 | 2015 |
| Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas CM Beltrami, MB Dos Reis, MC Barros-Filho, FA Marchi, H Kuasne, ... Clinical epigenetics 9, 1-11, 2017 | 77 | 2017 |
| Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors M Bisarro dos Reis, MC Barros-Filho, FA Marchi, CM Beltrami, H Kuasne, ... The Journal of Clinical Endocrinology & Metabolism 102 (11), 4089-4099, 2017 | 64 | 2017 |
| Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas SM Silveira, RAR Villacis, FA Marchi, MC Barros Filho, SA Drigo, CS Neto, ... PloS one 8 (6), e67643, 2013 | 61 | 2013 |
| Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact H Kuasne, MC Barros-Filho, A Busso-Lopes, FA Marchi, M Pinheiro, ... Oncotarget 8 (9), 15294, 2017 | 48 | 2017 |
| Down-Regulation of SLC8A1 as a Putative Apoptosis Evasion Mechanism by Modulation of Calcium Levels in Penile Carcinoma JJ Munoz, SA Drigo, MC Barros-Filho, FA Marchi, C Scapulatempo-Neto, ... The Journal of urology 194 (1), 245-251, 2015 | 48 | 2015 |
| Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma FA Marchi, DC Martins, MC Barros-Filho, H Kuasne, AF Busso Lopes, ... Scientific reports 7 (1), 6707, 2017 | 44 | 2017 |
| Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L‐thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer AB Santoro, DD Vargens, MC Barros Filho, DA Bulzico, LP Kowalski, ... British journal of clinical pharmacology 78 (5), 1067-1075, 2014 | 43 | 2014 |
| Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer CMS Silva, MC Barros-Filho, DVT Wong, JBH Mello, LMS Nobre, ... Cancers 13 (7), 1493, 2021 | 42 | 2021 |
| Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy MAA Koike Folgueira, H Brentani, DM Carraro, ... Oncology reports 22 (4), 805-813, 2009 | 42 | 2009 |
| Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma IMDP Ortiz, MC Barros-Filho, MB Dos Reis, CM Beltrami, FA Marchi, ... Clinical epigenetics 10, 1-13, 2018 | 38 | 2018 |
| Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients RML Lapa, MC Barros-Filho, FA Marchi, MAC Domingues, ... Oral oncology 93, 76-84, 2019 | 32 | 2019 |
| Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker RAR Villacis, SM Silveira, MC Barros-Filho, FA Marchi, MAC Domingues, ... PloS one 9 (7), e102281, 2014 | 30 | 2014 |
| Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancerpatients MC Barros Filho, MLH Katayama, H Brentani, APS Abreu, EM Barbosa, ... Brazilian Journal of Medical and Biological Research 43 (12), 1225-1231, 2010 | 30 | 2010 |
| Oncogenic drivers in 11q13 associated with prognosis and response to therapy in advanced oropharyngeal carcinomas MC Barros-Filho, LA Reis-Rosa, M Hatakeyama, FA Marchi, T Chulam, ... Oral oncology 83, 81-90, 2018 | 29 | 2018 |
| An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas PDR Cirilo, FA Marchi, MC Barros Filho, RM Rocha, MAC Domingues, ... PloS one 8 (3), e57901, 2013 | 28 | 2013 |
| Circulating mRNA signature as a marker for high-risk prostate cancer MF De Souza, H Kuasne, MDC Barros-Filho, HL Cilião, FA Marchi, ... Carcinogenesis 41 (2), 139-145, 2020 | 25 | 2020 |
| PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas FB Bertonha, M de Camargo Barros Filho, H Kuasne, PP Dos Reis, ... Molecular oncology 9 (2), 450-462, 2015 | 24 | 2015 |
